The WACC of Pharmaids Pharmacuticals Ltd (524572.BO) is 13.0%.
| Range | Selected | |
| Cost of equity | 12.10% - 14.40% | 13.25% |
| Tax rate | 16.40% - 23.90% | 20.15% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 11.9% - 14.1% | 13.0% |
| Category | Low | High |
| Long-term bond rate | 6.9% | 7.4% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 0.64 | 0.7 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 12.10% | 14.40% |
| Tax rate | 16.40% | 23.90% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 11.9% | 14.1% |
| Selected WACC | 13.0% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 524572.BO:
cost_of_equity (13.25%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.64) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.